Of interest, extracting SMYD2 expression values from the Oncomine cancer array database [42] revealed that SMYD2 levels in AML are lower than in Acute Lymphoblastic Leukemia (ALL) (Supplementary Figure 8). The gene discussed is SMYD2; the disease is acute myeloid leukemia.